Bacillus subtilis is a well-studied bacterium, often used as a model for cell differentiation and for industrial applications . Bacillus species can secrete virulent proteins, such as hemolysin, protease, phospholipase, toxin, and cytotoxin . They also exhibit swimming and swarming motility and possess the ability for intracellular survival and escape .
Bacillus subtilis is utilized in the production of recombinant proteins because of its secretion capabilities, high yield, and non-toxic nature . Approaches to optimize recombinant protein production in Bacillus subtilis include :
Optimization of Bacillus subtilis strains by chemical/physical mutagenesis, selection, and genetic manipulation.
Enhancement and regulation of expression through autonomous plasmid and integrated expression, promoter regulation and engineering, and fine-tuning gene expression based on proteases and molecular chaperones.
Improvement of secretion level, predominantly involving secretion pathway and signal peptide screening and optimization.
Surface display of proteins on spores or vegetative cells.
Fermentation optimization through medium optimization, process condition optimization, and feeding strategy optimization.
While Bacillus subtilis is often considered non-pathogenic, some isolates exhibit virulence potential . For example, the Bacillus subtilis strain G7, isolated from a deep-sea hydrothermal vent, has unique genetic features and can be lethal to vertebrate animals when introduced artificially . G7 possesses genes associated with motility, toxicity, adhesion, invasion, immune escape, and intracellular survival . Compared to the wild-type strain NCIB 3610 T, the G7 genome contains many genomic alterations and a higher quantity of genomic islands, most of which are specific to G7 and may contribute to its lethality .
Bacillus subtilis can produce antimicrobial substances with broad-spectrum activity against drug-resistant pathogens . These metabolites include peptides, organic acids, exopolysaccharides, and antimicrobial compounds, which contribute to gut health, immune system modulation, and pathogen inhibition .
KEGG: bsu:BSU18290
STRING: 224308.Bsubs1_010100010081
The UPF0713 protein yngL in Bacillus subtilis is classified as a protein of unknown function, as indicated by the UPF (Uncharacterized Protein Family) designation. While its specific function remains to be fully elucidated, researchers can employ several approaches to investigate its potential roles:
Sequence homology analysis to identify conserved domains or motifs that might suggest function
Gene knockout studies to observe phenotypic changes
Protein-protein interaction studies to identify binding partners
Expression pattern analysis under various growth conditions
To begin characterization, researchers typically employ gene deletion methods using traditional homologous recombination or more modern CRISPR/Cas9 approaches as described for B. subtilis. The traditional gene manipulation protocol involves preparing competent B. subtilis cells from fresh cultures grown in LM medium (LB supplemented with 3 mM MgSO₄), followed by transformation with template DNA containing the desired genetic modification .
For effective expression of recombinant yngL protein, researchers should consider the following methodological approach:
Selection of an appropriate expression vector (e.g., pHT43-based systems, which have proven successful for other B. subtilis proteins)
Design of appropriate fusion tags to aid in purification and detection
Optimization of expression conditions
Based on successful approaches with other recombinant B. subtilis proteins, researchers can construct fusion proteins that include detection elements such as RFP, which allows for visualization of expression. The pHT43 plasmid system has been successfully used as a shuttle vector for protein expression in B. subtilis WB800N strain . Expression can be induced using IPTG (0.1M) when the bacterial culture reaches OD₆₀₀ = 0.5, followed by continued culture for approximately 3 hours .
The expressed protein can be evaluated using Western blotting with appropriate antibodies, and visualization can be accomplished using an ECL detection system .
Several genome editing approaches can be employed for studying yngL in B. subtilis, each with specific advantages:
| Method | Time Required | Advantages | Limitations |
|---|---|---|---|
| Traditional gene manipulation | 2-3 days | Simple, well-established | Limited to insertions/deletions with selectable markers |
| Clean deletion (pDR244) | 4-6 days | Marker-free deletions | Longer protocol, requires temperature shifts |
| Allelic exchange | 5-6 days | Allows for point mutations | Time-consuming, requires screening |
| CRISPR/Cas9 | 2-4 days | Precise, versatile | Requires design of effective guide RNAs |
For traditional gene manipulation, researchers can use a PCR fragment or plasmid with 100-500 bp flanking the site of exchange. The competency protocol involves growing B. subtilis in LM medium for 3 hours, transferring to MD medium for 4 hours, and then transforming with the DNA template .
For clean deletions, the pDR244 system utilizes LoxP sites to remove antibiotic resistance cassettes. This approach requires growth at specific temperatures (25°C and 37°C) to control plasmid maintenance and Cre recombinase expression .
CRISPR/Cas9-based methods offer precise genome editing capabilities and can be especially useful for studying yngL function through targeted mutations or deletions without leaving selection markers .
Investigating potential protein-protein interactions involving yngL requires a systematic approach:
Co-immunoprecipitation studies using tagged versions of yngL
Bacterial two-hybrid assays to screen for interaction partners
In situ localization studies to identify co-localization with known protein complexes
Of particular interest might be interactions with cytoskeletal elements such as MreB, which forms dynamic patches required for peptidoglycan synthesis in B. subtilis . Recent research has revealed that MreB is part of the elongasome complex involved in cell wall synthesis, and investigating potential yngL interactions with this complex could provide insights into its function .
For in situ studies, fluorescently tagged proteins can be expressed using the recombinant B. subtilis approach, where fusion constructs are created and transformed into B. subtilis using the competency protocol described earlier .
Understanding yngL's potential role in cell morphology requires a multifaceted approach:
Phase-contrast and fluorescence microscopy to observe morphological changes in yngL mutants
Time-lapse imaging to track developmental processes
Electron microscopy for ultrastructural analysis
B. subtilis cell morphology is governed by multiple systems, including the elongasome complex that incorporates the bacterial actin homologue MreB . Initially thought to form extended helical filaments, modern microscopy techniques have revealed that MreB forms dynamic patches that require active peptidoglycan synthesis for their movement . Investigating whether yngL affects these dynamic processes could provide insights into its function.
To investigate potential roles in development, researchers should also examine whether yngL expression changes during sporulation, a complex developmental process in B. subtilis that involves numerous protein-protein interactions and antisigma factors .
When faced with conflicting experimental results regarding yngL function, researchers should consider:
Strain background differences that might influence results
Experimental condition variations that affect protein expression or activity
Methodological differences in detection or analysis
The history of B. subtilis research provides instructive examples of initially contradictory findings that were later reconciled. For instance, research on the sporulation sigma factor SigF revealed apparently contradictory mechanisms of regulation: one involving protein-protein interactions with an antisigma factor, and another showing that the antisigma factor was actually a protein kinase . Both findings were eventually shown to be correct aspects of a more complex regulatory system.
This suggests that seemingly contradictory findings about yngL might represent different facets of its function or regulation that need to be integrated into a comprehensive model.
For optimal transformation efficiency when studying yngL, researchers should follow these specific steps for preparing competent B. subtilis:
Grow a fresh culture from a single colony in LM medium (LB supplemented with 3 mM MgSO₄) for 3 hours at 37°C with shaking at 200 rpm until reaching OD₆₀₀ of approximately 1.0
Transfer 20 μL of the LM culture to 500 μL MD medium and grow for 4 hours at 37°C to reach stationary phase
Use freshly prepared competent cells rather than frozen stocks for optimal transformation efficiency
Add 1-5 μL of template DNA (up to 100 ng) directly to the competent cells and incubate for 90 minutes at 37°C before plating on selective media
This protocol consistently produces competent cells suitable for introducing yngL constructs or creating yngL mutations in B. subtilis.
When encountering problems with yngL expression, researchers should systematically address potential issues:
| Issue | Possible Cause | Troubleshooting Approach |
|---|---|---|
| Low expression levels | Codon usage bias | Optimize codons for B. subtilis |
| Protein toxicity | Use inducible promoters with tight regulation | |
| Transcriptional issues | Check promoter strength and RBS efficiency | |
| Protein degradation | Protease activity | Use protease-deficient strains like WB800N |
| Structural instability | Consider fusion partners to enhance stability | |
| Insoluble protein | Improper folding | Optimize growth temperature and induction conditions |
| Hydrophobic regions | Use solubility-enhancing tags |
The WB800N strain of B. subtilis is particularly useful for recombinant protein expression as it lacks eight extracellular proteases, which can significantly improve protein yield and stability .
For protein detection, Western blotting with appropriate antibodies can verify expression, and visualization can be accomplished using the Super ECL Plus system as demonstrated with other recombinant B. subtilis proteins .
Given B. subtilis' importance as a model for studying cell wall synthesis, investigating yngL's potential role in this process represents a promising research direction:
Co-localization studies with components of the elongasome complex
Interaction studies with SEDS proteins (like RodA) that function as glycosyltransferases in peptidoglycan synthesis
Analysis of cell wall composition and structure in yngL mutants
Recent discoveries have highlighted the role of the SEDS-protein RodA as a glycosyltransferase responsible for peptidoglycan synthesis . This protein functions within the elongasome complex, which includes the bacterial actin homologue MreB that forms dynamic patches along the cell membrane. These patches require active peptidoglycan synthesis for their dynamics .
To investigate potential interactions, researchers could create fluorescently tagged yngL and components of the cell wall synthesis machinery, then examine their localization patterns using advanced microscopy techniques.
While specific immunological properties of yngL remain to be determined, the successful use of recombinant B. subtilis for vaccine delivery provides a methodological framework:
Construction of fusion proteins combining yngL with immunogenic epitopes
Assessment of mucosal immune responses following oral administration
Evaluation of serum antibody responses
The success of recombinant B. subtilis in expressing viral antigens and inducing both mucosal and systemic immune responses demonstrates the potential of this approach . Studies have shown that recombinant B. subtilis can effectively induce secretory IgA (sIgA) in the intestinal tract and stimulate serum IgG production when engineered to express viral antigens .
To investigate such applications, researchers would need to construct recombinant B. subtilis strains expressing yngL or yngL-fusion proteins, then evaluate their immunogenicity through controlled animal studies similar to those described for other B. subtilis-expressed antigens .